GLP-1 Savings Programs and Discount Cards: What's Available
Brand-name GLP-1 medications are expensive without insurance or a savings program, and that is a real barrier for many people. There are several ways the cost can come down: manufacturer savings cards, manufacturer self-pay options, pharmacy discounts, insurance coverage, tax-advantaged accounts, and cash-pay compounded options. This guide walks through each one and what to check.
Transformation Health is an independent guide, not a provider: we do not prescribe, sell medication, or run savings programs. This content is for general education and is not medical advice. Talk with a licensed provider about your situation.
Why brand-name GLP-1 medications cost so much
Brand-name GLP-1 medications (semaglutide and tirzepatide) are expensive in part because they are under patent protection, and there are no FDA-approved generic versions of either in the US yet. The companies that developed them set the list price.
Insurance companies negotiate discounted rates for their members, but people paying cash without a discount program can face the full retail price.
Manufacturer savings programs for brand-name medications
Both the semaglutide and tirzepatide manufacturers offer savings cards designed to reduce out-of-pocket costs for patients with commercial insurance, and both offer separate self-pay options.[1][2]
What savings cards typically do:
- Reduce your copay or coinsurance if you have qualifying commercial insurance
- Apply only to brand-name medications, not compounded versions
- Have monthly or yearly savings caps and an expiration date
- Change frequently, and the manufacturer can modify or end them
Important limitations (terms as of 2026-10-16):
- Insurance type. The Wegovy savings offer is for patients with commercial insurance and excludes government beneficiaries.[1] The Zepbound savings card requires a commercial drug plan and excludes people enrolled in government-funded programs, such as Medicaid, Medicare, or VA coverage.[2]
- Other conditions. The Zepbound card terms require US or Puerto Rico residency, age 18 or older, and a prescription for an FDA-approved use; they list state-specific exceptions for Massachusetts and California residents when a generic or therapeutic equivalent is available; and the card expires 12/31/2026.[2]
- Income. Neither savings card page listed an income limit. Patient assistance programs, a separate type of help, can have income and insurance requirements; NeedyMeds keeps a searchable database of them.[3]
- Enrollment is required, and programs can be discontinued or changed.
Self-pay options: For people without coverage, both manufacturers list self-pay options. Wegovy self-pay prescriptions are filled through NovoCare Pharmacy, and the price varies by dose.[1] Lilly’s Zepbound page lists a KwikPen self-pay offer for patients without insurance, on Medicare, or with government coverage, ordered through LillyDirect Pharmacy or another pharmacy; self-pay costs cannot be submitted to insurance or applied to a deductible.[2] Check each manufacturer’s current page for prices.
Where to find current information:
Do not rely on a website (including this one) for current program terms. Manufacturer savings programs change frequently. Visit the manufacturer website directly or ask your pharmacy to check what programs you might qualify for.
Pharmacy discount services (GoodRx and similar)
GoodRx and similar prescription discount services offer coupons that can reduce the cash price of some brand-name GLP-1 medications at participating pharmacies. They are separate from insurance.
How it works:
- Search for your medication and dose on the discount service’s website or app
- See listed prices at pharmacies near you
- Present the coupon or code at the pharmacy
- Pay the discounted cash price
What to expect:
- Discounts vary significantly by pharmacy and location
- You generally use a discount service instead of your insurance, so you pay cash
- Compare your insurance copay, the discounted cash price, and the manufacturer’s self-pay price to see which costs less
Reality check:
Even with a discount, brand-name GLP-1 medications can remain expensive. Prices vary by pharmacy, program, and dose, so compare the current options side by side.
Medicare and Medicaid coverage
Medicare and Medicaid have different coverage rules for GLP-1 medications.
Medicare Part D:
Federal law lets Part D exclude “agents when used for anorexia, weight loss, or weight gain,” so Part D plans generally do not cover GLP-1 medications prescribed only for weight management.[4][5] Plans may cover a GLP-1 for another FDA-approved use, such as type 2 diabetes, usually with plan rules such as prior authorization.
The Medicare GLP-1 Bridge: CMS is running a short-term demonstration, the Medicare GLP-1 Bridge, that provides eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs from July 1, 2026 through December 31, 2027. It operates outside the Part D benefit’s coverage and payment flow, so it does not change the statutory exclusion. As of 2026-10-16, the CMS page lists a flat copay, notes that the Part D deductible does not apply, and says no low-income subsidy is provided.[6] Eligibility criteria and covered products are set by CMS and can change, so check the CMS page or call 1-800-MEDICARE.
Bills to let Medicare cover anti-obesity medications have been proposed, but as of 2026-10-16 the exclusion is still in the statute.[4][5] Do not assume coverage based on pending legislation. For more detail, see Medicare Part D and weight loss medications.
Medicaid:
Medicaid coverage varies by state. Federal law lets state Medicaid programs exclude drugs used for weight loss, and CMS says Medicare and Medicaid currently generally do not cover GLP-1s for the weight loss indication.[5][7] Some states do cover them, and CMS’s voluntary BALANCE Model may change state decisions.[7] Contact your state Medicaid office or your plan to find out whether weight loss medications are covered under your plan.
FSA and HSA accounts
Whether a Flexible Spending Account (FSA) or Health Savings Account (HSA) can pay for a GLP-1 prescription is a tax and plan question.
What the IRS says:
- IRS Publication 502 (2025) says you can include amounts you pay for prescribed medicines in medical expenses.[8]
- IRS Publication 969 (2025) says qualified medical expenses for HSAs and health FSAs are generally those that would qualify for the medical expense deduction; for an FSA, they are the expenses specified in the plan.[9]
How to verify eligibility:
Contact your FSA or HSA plan administrator, or a tax professional, to confirm your specific plan’s rules before you pay, especially if a program’s monthly fee bundles medication with other services. Whether a program accepts HSA or FSA cards is up to that program.
The compounded alternative: program options to review
For people without insurance coverage, or for whom copays and prior authorization delays are too burdensome, some cash-pay telehealth programs prescribe compounded semaglutide or tirzepatide prepared by a compounding pharmacy.
If you have commercial insurance
Manufacturer savings cards and pharmacy discounts may be available. Start by asking your pharmacy what programs you qualify for. Your cost depends on your plan, your copay, and the program's current terms.
If you are uninsured or underinsured
Compare manufacturer self-pay options with cash-pay telehealth programs, including those that prescribe compounded medications. Prices vary by program and dose, so compare the total cost: medication, dose increases, visits, labs, shipping, membership fees, and cancellation terms.
What to confirm before you choose a program:
- Which medication and dose the monthly price covers, and whether the price changes as the dose increases
- Whether provider visits, follow-ups, and lab work are included or billed separately
- Which pharmacy prepares or fills the medication, and that pharmacy’s state license
- Shipping, membership, or setup fees
- Cancellation terms, including whether you are billed in advance
- Which payment methods the program accepts
“All-inclusive” is a program’s own label, and it means different things at different programs. Check each program’s current pricing page.
Important distinction:
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name products.[10] A licensed provider decides whether a compounded medication is appropriate for your health history.
Transformation Health does not accept payment from providers. How we make money.
How to choose: a decision framework
If you are trying to decide which option makes sense for your situation:
Do you have commercial insurance? Start with your pharmacy or the manufacturer website. Ask whether savings programs are available. Get quotes.
Are you on Medicare or Medicaid? Contact your plan to confirm coverage, and check whether you are eligible for the Medicare GLP-1 Bridge. Manufacturer savings cards generally exclude government coverage, but some manufacturer self-pay options do not.
Do you have an FSA or HSA? Confirm with your plan administrator what the account can pay for before you compare options.
No insurance coverage available? Compare manufacturer self-pay prices and cash-pay programs on their total cost and terms.
A licensed provider can help you weigh the clinical side of these options; your plan, pharmacy, or a tax professional can answer the coverage and cost questions.
How the process should work
At most cash-pay telehealth programs, you complete an online intake form covering your health history, a licensed provider reviews it and decides whether a prescription is appropriate, and if it is, the prescription goes to a pharmacy. Some states require a live video visit before certain prescriptions can be written; a program should tell you if that applies where you live.
Before you sign up, read the program’s terms for what the monthly fee covers, what is billed separately, and how cancellation works.
We're relaunching soon
We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.
Get StartedKey takeaways
- Brand-name GLP-1 medications are expensive without insurance or a savings program
- Manufacturer savings cards can reduce costs for people with commercial insurance, but they exclude government coverage and change frequently. Check the manufacturer website directly for current terms
- Manufacturer self-pay options and pharmacy discount services can lower the cash price; compare them against each other and your copay
- The Medicare Part D benefit generally does not cover GLP-1s for weight loss alone, though the temporary Medicare GLP-1 Bridge reaches eligible Part D enrollees; Medicaid coverage varies by state
- Whether FSA or HSA funds apply depends on IRS rules and your plan
- Cash-pay programs, including those that prescribe compounded medications, vary in price and terms; compare the total cost
The most cost-effective choice varies by person, based on insurance status, savings program eligibility, and financial circumstances.
Citations
[1] Novo Nordisk. “Save on Wegovy” (coverage and savings). Accessed 2026-10-16. https://www.wegovy.com/coverage-and-savings/save-on-wegovy.html
[2] Eli Lilly and Company. “Zepbound Coverage and Savings.” Accessed 2026-10-16. https://zepbound.lilly.com/coverage-savings
[3] NeedyMeds. “Patient Assistance Programs Database.” Accessed 2026-10-16. https://www.needymeds.org/
[4] 42 U.S.C. 1395w-102(e)(2)(A) (definition of covered Part D drug; exclusions). https://www.law.cornell.edu/uscode/text/42/1395w-102
[5] 42 U.S.C. 1396r-8(d)(2)(A) (drugs that may be excluded or restricted: “agents when used for anorexia, weight loss, or weight gain”). https://www.law.cornell.edu/uscode/text/42/1396r-8
[6] Centers for Medicare and Medicaid Services. “Medicare GLP-1 Bridge.” Accessed 2026-10-16. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
[7] Centers for Medicare and Medicaid Services. “BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model.” Accessed 2026-10-16. https://www.cms.gov/priorities/innovation/innovation-models/balance
[8] Internal Revenue Service. “Publication 502 (2025), Medical and Dental Expenses.” https://www.irs.gov/publications/p502
[9] Internal Revenue Service. “Publication 969 (2025), Health Savings Accounts and Other Tax-Favored Health Plans.” https://www.irs.gov/publications/p969
[10] U.S. Food and Drug Administration. “Compounding and the FDA: Questions and Answers.” https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
Important: This content is for general education and is not medical advice. Talk with a licensed provider about your situation. transformationhealth.com is a website operated by Amerigo Health LLC. Transformation Health is an independent publisher. It does not provide medical care, prescribe, or sell medication, and does not give medical advice. A licensed provider decides whether a prescription is appropriate. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name products. Manufacturer savings program eligibility and terms change frequently; check manufacturer websites directly for current information. Wegovy is a trademark of Novo Nordisk A/S. Zepbound is a trademark of Eli Lilly and Company. Transformation Health is not affiliated with or endorsed by these companies. Transformation Health does not accept payment from providers. How we make money.